Literature DB >> 18386292

Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study.

M Cortesi1, E Fridman, A Volkov, S Sh Shilstein, R Chechik, A Breskin, D Vartsky, N Kleinman, G Kogan, E Moriel, V Gladysh, M Huszar, J Ramon, G Raviv.   

Abstract

BACKGROUND: The correlation between Zinc concentration in the prostate's peripheral zone to the onset or presence of malignant process needs to be evaluated in detail.
METHODS: Zinc concentration was measured in approximately 1-4 mm3 segments of fresh needle-biopsy cores, with X-ray fluorescence, and correlated with the histological findings of these tissue segments.
RESULTS: Local Zinc concentration is correlated with the presence of cancer (PCa); the higher the Gleason score the greater the Local Zinc depletion. The Zinc value averaged over the entire extracted tissue is specific only to Gleason score 8-9 PCa. The results refer to patients avoiding Zinc-rich supplements since those show elevated prostatic Zinc concentration in identified cancer tissue. A computer simulation analysis of randomly located 0.03-3.3 cm3 lesions, with particular Gleason score and the measured Local Zinc concentration, revealed a potential diagnostic approach definitely superior to PSA, with sensitivity to the tumor grade and with excellent detection capability for Gleason score >6. Further clinical studies have been designed, both on full prostates after radical prostatectomy as well as on biopsy cores at higher resolution, to establish the accuracy of the method for Gleason score = 6.
CONCLUSIONS: The PCa diagnostic potential of Local Zinc concentration is confirmed and there is indication that the amount of Zinc depletion could be used as a measure of the Gleason score of the tumor. Local Zinc concentration mapping has the potential to improve patient selection for biopsy, biopsy site selection and local therapy (e.g., Cryotherapy, Brachytherapy) site selection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18386292     DOI: 10.1002/pros.20766

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  21 in total

Review 1.  Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Expert Rev Anticancer Ther       Date:  2012-01       Impact factor: 4.512

Review 2.  The genetic/metabolic transformation concept of carcinogenesis.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

3.  Evidence that Human Prostate Cancer is a ZIP1-Deficient Malignancy that could be Effectively Treated with a Zinc Ionophore (Clioquinol) Approach.

Authors:  Leslie C Costello; Renty B Franklin; Jing Zou; Michael J Naslund
Journal:  Chemotherapy (Los Angel)       Date:  2015-06

4.  Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma.

Authors:  Leslie C Costello; Bernard A Levy; Mohamed M Desouki; Jing Zou; Omar Bagasra; Leslie A Johnson; Nader Hanna; Renty B Franklin
Journal:  Cancer Biol Ther       Date:  2011-08-15       Impact factor: 4.742

Review 5.  A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Arch Biochem Biophys       Date:  2016-04-27       Impact factor: 4.013

Review 6.  Metabolic targets for potential prostate cancer therapeutics.

Authors:  Jeffrey Twum-Ampofo; De-Xue Fu; Antonino Passaniti; Arif Hussain; M Minhaj Siddiqui
Journal:  Curr Opin Oncol       Date:  2016-05       Impact factor: 3.645

7.  Zinc as an Imaging Biomarker of Prostate Cancer.

Authors:  Su-Tang Lo; André F Martins; Veronica Clavijo Jordan; A Dean Sherry
Journal:  Isr J Chem       Date:  2017-07-31       Impact factor: 3.333

8.  hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1).

Authors:  Jing Zou; Beatrice C Milon; Mohamed M Desouki; Leslie C Costello; Renty B Franklin
Journal:  Prostate       Date:  2011-02-25       Impact factor: 4.104

Review 9.  Zinc and zinc transporters in prostate carcinogenesis.

Authors:  Vladimir Kolenko; Ervin Teper; Alexander Kutikov; Robert Uzzo
Journal:  Nat Rev Urol       Date:  2013-03-12       Impact factor: 14.432

10.  Risk stratification of prostate cancer patients based on EPS-urine zinc content.

Authors:  Zdravka Medarova; Subrata K Ghosh; Mark Vangel; Richard Drake; Anna Moore
Journal:  Am J Cancer Res       Date:  2014-07-16       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.